The NOR-COR Study for Coronary Prevention

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

975 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-02-28

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The NOR-COR study is a cross-sectional, observational study designed to explore a large number of cardiovascular, inflammatory, genetic, behavioral, and psychosocial factors (including anxiety, depression, quality of life) in 1369 patients with established coronary heart disease (CHD) hospitalized in the Sections for Cardiology at the hospitals in Drammen (n=722) and Vestfold (n=647). Study data from an extensive questionnaire, clinical and laboratory data, and sputum/saliva for genetic analyses will be collected.

The main overall aim of the NOR-COR study is to develop new strategies to improve secondary prevention for underserved high risk patient-groups with CHD. The first study phase aims to collect information necessary to develop empirically based future secondary coronary prevention interventions. In a genetic sub-project markers associated with CHD and personality type will be explored.

The study will evaluate current secondary preventive programs and explore the mechanisms that link behavioral, psychosocial, inflammatory, and genetic factors to poor prognosis. The study will in short term provide new knowledge potentially useful for increasing participation in current cardiac rehabilitation/secondary preventive programs. For a longer perspective these associations may be useful for design of new intervention programs to selected high risk patient groups whom may be in need of programs with different content and/or of longer duration than those currently being applied.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Screening for Depression and Anxiety in Patients With Heart Disease

NCT03203395

Depression Depressive Symptoms Depressive Disorder +5 more

COMPLETED NA

Patient-reported Outcomes After Percutaneous Coronary Intervention

NCT03810612

Coronary Artery Disease

ACTIVE_NOT_RECRUITING

Risk Reduction in Coronary Heart Disease

NCT00679237

Coronary Heart Disease

COMPLETED NA

Fighting Social Inequality in Cardiovascular Health I

NCT03946956

Cardiac Disease Vascular Diseases

COMPLETED NA

Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use

NCT04398563

Heart Failure Heart Failure With Preserved Ejection Fraction Heart Failure With Reduced Ejection Fraction

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Secondary Coronary Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

coronary heart disease patients

no intervention

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients aged 18-80 years with first or recurrent diagnosis or treatments for CHD: a) acute myocardial infarction \[ICD-10; I21\], b) coronary artery by-pass graft operation (CABG), or c) elective or emergency PCI \[ICD-10; I25\]) have been identified from hospital patient discharge lists (diagnostic lists) by searching chronologically after last admission the past three years. In patients with recurrent diagnosis the last event will define the event.

Exclusion Criteria

* Cognitive impairment that would invalidate assessment including all patients living at nursing home and psychosis.
* Short life expectancy (i.e. \<1 year) due to terminal heart (NYHA class 4), lung (chronic obstructive pulmonary disease GOLD 4)-, liver- or kidney disease (chronic kidney disease stage 5), malignant disease, or other reason.
* Not able to understand and write the Norwegian language or refuse to give written informed consent to study participation.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes